Related Experiment Video
Updated: Aug 16, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Hepatitis B virus genotypes and extrahepatic manifestations
Patrice Cacoub1, David Saadoun, Marc Bourlière
1Department of Internal Medicine, Hôpital La Pitié-Salpêtrière, 83 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France. patrice.cacoub@psl.ap-hop-paris.fr
Insights
This study found no link between hepatitis B virus (HBV) genotypes and extrahepatic manifestations in chronic HBV patients. Further research is needed to understand these complex conditions.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis B virus (HBV) infection is a global health concern.
- Extrahepatic manifestations (EHMs) are common in patients with chronic HBV.
- The role of HBV genotypes in the development of EHMs remains unclear.
Purpose of the Study:
- To investigate the correlation between specific hepatitis B virus (HBV) genotypes and the occurrence of extrahepatic manifestations (EHMs) in patients with chronic HBV infection.
- To identify potential viral or host factors associated with EHMs in this population.
Main Methods:
- A national, multicenter, retrospective, cross-sectional study was conducted in France.
- 190 patients with chronic HBV infection (HBsAg-positive for ≥6 months) had their HBV genotypes determined prior to treatment.
- Clinical and biological extrahepatic manifestations were assessed and correlated with epidemiological, viral, and hepatic factors.
Main Results:
- Among 190 patients, 16% had clinical EHMs and 15% had biological EHMs. Clinical EHMs were not associated with HBV genotypes but correlated with higher platelet counts.
- Biological EHMs were associated with anti-HBe antibody positivity and elevated platelet counts.
- Carriage of precore mutant HBV was linked to an increased risk of biological EHMs.
Conclusions:
- No association was found between hepatitis B virus (HBV) genotypes and the presence of either clinical or biological extrahepatic manifestations in patients with chronic HBV infection.
- Platelet count and precore mutant HBV carriage emerged as potential factors associated with EHMs, warranting further investigation.
Background/Aims:
This study aimed at correlating the presence of extrahepatic manifestations with hepatitis B virus (HBV) genotypes in patients with chronic HBV infection.
Methods:
This was a national (France), multicenter, retrospective, cross-sectional study. HBV genotypes were determined in 190 patients HBsAg-positive for at least 6 months and documented before any treatment.
Results:
Patients were aged 42+/-15 years and mainly male (77%). Alcohol intake was high in 6% of them, ALT elevated in 73%; 27% were cirrhotic. All HBV genotypes were found, mainly A (24%), D (29%), C (11%), and E (10%). Thirty (16%) patients had clinical extrahepatic manifestations, mainly sensory-motor deficiency, sicca syndrome, myalgia, glomerulonephritis, and arthralgia-arthritis. Their presence was not related to any epidemiologic, viral (including genotypes) or hepatic factor, but to a higher platelet count (P=0.004). Twenty-nine (15%) patients had biological extrahepatic manifestations, mainly anti-smooth muscle, antinuclear, and anti-nucleosome antibodies. Their presence was related only to anti-HBe antibodies positivity (P=0.007) or elevated platelet count (P=0.003). Carrying precore mutant HBV increased by 2.8 folds the risk to have at least one extrahepatic biological manifestation.
Conclusions:
No relationships between HBV genotypes and the presence of extrahepatic manifestations were evidenced in patients with chronic HBV infection.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Genital Herpes
Cytomegalovirus Disease
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

